Here are relevant reports on : scaling-and-corrosion-inhibitors-market
-
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2028
The global plasma fractionation market, valued at US$27.2 billion in 2022, stood at US$29.0 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2025 to 2028, culminating in a forecasted valuation of US$40.4 billion by the end of the period. Market growth is driven mainly by factors such as the growing use of immunoglobulins in various therapeutic areas, strategic expansion of plasma collection centers/inventories by market players, and the growing prevalence of respiratory diseases and AATD
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecast to 2026
The global prostate health market growth is primed to transition from USD 31.8 billion in 2021 to USD 48.9 billion by 2026, showcasing a strong CAGR of 9.0%. Growth in this market is primarily driven by the increasing prevalence of benign prostatic hyperplasia, increasing obesity, investments, funds, and grants for research in prostate health, an increase in the prevalence of prostate cancer, a surge in demand for hormone therapy drugs, emerging therapies for prostate cancer, and an increasing incidence of prostatitis.
- Published: December 2021
- Price: $ 4950
- TOC Available:
-
Insect Growth Regulators Market by Type (Chitin Synthesis Inhibitors, Juvenile Hormone Analogs & Mimics, Anti-juvenile Hormone Agents), Form, Application (Agricultural, Livestock Pests, Commercial Pest Control), and Region - Forecast to 2022
The global insect growth regulators market is estimated at USD 736.3 Million in 2016 and is projected to reach USD 1,054.3 Million by 2022, at a CAGR of 6.16% during the forecast period. The market is driven by factors such as adoption of environmentally safe crop protection products and rise in application scope of insect growth regulators in commercial pest control usage.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021
The global cancer immunotherapy market size is projected to grow at a CAGR of 14.0%. Market growth can be attributed to the increasing incidence of cancer, rising demand for therapies with minimal adverse effects, increase in adoption of immunotherapy over other treatment options, and enhanced drug development process. However, stringent regulatory policies and the highly consolidated market which may create an obstacle for the entry of small players are the major factors restraining the growth of this market.
- Published: September 2016
- Price: $ 4950
- TOC Available:
-
Aqueous-based Metal Cleaners Market by Cleaning Chemicals (Builders, Sequestrants & Inhibitors, Surfactants), End-use Industries (Manufacturing, Automotive & Aerospace, Healthcare), Chemistry Type, Technology and Region- Global Forecast to 2027
The aqueous-based metal cleaners market is expected to grow from USD 11.2 billion in 2022 to USD 14.6 billion by 2027, at a CAGR of 5.4% during the forecast period. The key market players profiled in the report include BASF SE (Germany), Dow Inc. (US), Stepan Company (US), Evonik Industries AG (Germany), Eastman Chemical Company (US), Nouryon (Netherlands), Clariant AG (Switzerland), The Chemours Company (US), Indorama Ventures Public Company Limited (Thailand), Ashland Global Holdings Inc. (US) and among others.
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Inflammatory Bowel Disease Treatment Market by Type (Crohn’s Disease, Ulcerative Colitis), Drug Class (TNF inhibitors, Corticosteroids, Aminosalicylates, JAK inhibitors, Anti-intergin, IL inhibitors, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Route of Administration (Oral, Injectable) and Region – Global Forecast to 2027
The global inflammatory bowel disease market is projected to reach USD ~32 billion by 2027 from 24 billion in 2022, at a CAGR of 5% during the forecast period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Corrosion Inhibitors Market by Compound(Organic, Inorganic), Type(Water Based, Oil Based and VCI), Application, End-Use (Power Generation, Oil & Gas, Metal & Mining, Pulp & Paper, Utilities, Chemical), and Region - Global Forecast to 2026
The Corrosion Inhibitors Market is expected to grow from USD 7.9 billion in 2021 to USD 10.1 billion by 2026, at a CAGR of 4.9% during the forecast period. Major players operating in the global corrosion inhibitor market include Solenis (US), Nouryon (The Netherlands), Baker Hughes Company (US), Ecolab (US), BASF SE (Germany), SUEZ Water Technologies & Solutions (France), DOW Chemical Company (US), Lubrizol Corporation (US), Lanxess (Germany), and Henkel Corporation (Germany).
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
Renal Cancer Drugs Market by therapy (targeted therapy, chemotherapy, and immunotherapy), drug class (anti-angiogenesis, mTOR inhibitors, interleukin, and immune checkpoint inhibitors), indication (renal cell carcinoma, urothelial carcinoma, and others), distribution channel (hospitals, specialty & retail pharmacies and others), and region (North America, Europe, Asia Pacific and Rest of the World (RoW) which includes Latin America and Middle East & Africa) – global forecasts to 2027
The renal cancer drugs market is projected to reach USD 8 billion by 2027 from USD 6 billion in 2022, at a CAGR of 6% during the forecast period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Aviation Fuel Additives Market by Application (Civil Aviation, Military), by Fuel Type (Avgas, Jet Fuel), by Additive Type (Deposit Control, Anti-Icing, Corrosion Inhibitor and Lubricity Improver, Biocides, Anti-Oxidants, Dyes & Maker, and Others) - Forecast & Analysis to 2015 - 2020
The aviation fuel additives market has great potential to grow, at a projected CAGR of 9.4% from 2015 to 2020. This report provides qualitative and quantitative information about the aviation fuel additives market. It identifies the market application gaps, emerging technologies, the need for new product launches, and high potential geographic regions and countries. It also provides a segmentation of the market, tracking the market size, market share, revenue projections, and financial portfolio, covering a broad spectrum of the aviation fuel additives market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
